Aadi Bioscience, Inc. (ARPO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vaxart, Inc.

Prelude Therapeutics, Inc.

Sonnet BioTherapeutics Holdings, Inc.

Sangamo Therapeutics, Inc.

Century Therapeutics, Inc.

Greenwich LifeSciences, Inc.

Aadi Bioscience, Inc.

Theseus Pharmaceuticals, Inc.

Galectin Therapeutics, Inc.

PepGen Inc.

XBiotech, Inc.

Why is Aadi Bioscience, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Aadi Bioscience, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Aadi Bioscience, Inc.

115.61%

2.03

75.80%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-13.77%

EBIT Growth (5y)

-274.08%

EBIT to Interest (avg)

-48.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.04

Sales to Capital Employed (avg)

0.22

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

83.72%

ROCE (avg)

ROE (avg)

2.73%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.09

EV to EBIT

-0.03

EV to EBITDA

-0.03

EV to Capital Employed

-0.37

EV to Sales

0.48

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-15.11%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -105.91 %

-21What is not working for the Company

PRE-TAX PROFIT(Q)

At USD -22.19 MM has Fallen at -130.4%

NET PROFIT(Q)

At USD -22.19 MM has Fallen at -130.4%

OPERATING CASH FLOW(Y)

Lowest at USD -107.78 MM

ROCE(HY)

Lowest at -68.54%

RAW MATERIAL COST(Y)

Grown by 101.13% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

Here's what is working for Aadi Bioscience, Inc.

Debt-Equity Ratio

Lowest at -105.91 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Aadi Bioscience, Inc.

Pre-Tax Profit

At USD -22.19 MM has Fallen at -130.4%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -22.19 MM has Fallen at -130.4%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -107.78 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 101.13% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales